The global clinical perinatal software market size is expected to reach USD 303.9 million in 2030 and is expected to witness a CAGR of 10.3% from 2025 to 2030. The increasing number of stillbirth cases globally is boosting the market growth.
Integrated software product segment held the largest market share in terms of revenue in 2024. Increasing demand for the workflow integration of medical professionals is anticipated to drive the growth of this segment in the forthcoming years. Moreover, technological advancements and growing adoption are the factors projected to continue fueling the segment growth over the forecast period.
In terms of application, fetal monitoring data services held the largest revenue share in 2024. These services provide accurate and adequate monitoring of fetal heartbeat and uterine contraction. Mobile fetal monitoring allows patients to remotely access the data to track the fetal development. This factor is projected to positively influence the segment growth during the forecast period.
Supportive government initiatives for maintaining maternal health are increasing the adoption of clinical perinatal software. Moreover, adoption and implementation of healthcare IT solutions such as monitoring systems in clinics, hospitals and surgical centers have increased the efficiency of work and reduced healthcare expenditure, thereby propelling the market growth.
The industry players are taking initiatives to develop new software with added data security, thus propelling further growth. For instance, in May 2018 Myriad Genetics acquired Counsyl in order to improve its portfolio in noninvasive prenatal screening.
Request a free sample copy or view report summary: Clinical Perinatal Software Market Report
On basis of product, integrated segment held the largest revenue share of 80.0% in 2024 owing to the increased adoption of this software among healthcare and clinics
On basis of deployment model, on-premise segment held the largest revenue share, over 70.8%, in 2024 owing to its data security and ease of access
On basis of application, workflow management software is expected to exhibit the fastest CAGR over the forecast period owing to its increased productivity and increasing adoption
On basis of end use, hospitals and clinics dominated the market for clinical perinatal software in terms of revenue share in 2019 owing to the presence of advanced technology and increased footfall
Asia Pacific is expected to exhibit the fastest CAGR over the forecast period. The growth can be attributed to an increase in disposable income and supportive government initiatives
Grand View Research has segmented the global clinical perinatal software market based on product, deployment model, application, end-use, and region.
Clinical Perinatal Software Product Outlook (Revenue, USD Million, 2018 - 2030)
Integrated
Standalone
Clinical Perinatal Software Deployment Model Outlook (Revenue, USD Million, 2018 - 2030)
On-premise
Cloud-based
Clinical Perinatal Software Application Outlook (Revenue, USD Million, 2018 - 2030)
Fetal monitor data services
Workflow management
Patient documentation
Clinical Perinatal Software End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital/Clinics
Maternity Clinics
Clinical Perinatal Software Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Thailand
South Korea
Australia
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Clinical Perinatal Software Market
PeriGen, Inc.
Koninklijke Philips N.V.
Trium Analysis Online GmbH
EDAN Instruments, Inc.
K2 Medical Systems Ltd.
Huntleigh Healthcare Limited.
Clinical Computer Systems, Inc.
GE HealthCare
"The quality of research they have done for us has been excellent..."